FPR1 and neurodegenerative disease: Given all these possibilities for fMLP to enter the CNS and the innate vulnerabilities of the nigrostriatal dopaminergic system (Block et al. 2007), the results of the present study highlight the potential role of infectious agents in neurodegenerative diseases and may aid in the development of new therapies.